Thailand Breaks Merck's Patent For AIDS Drug

Law360, New York (December 4, 2006, 12:00 AM EST) -- Going over the heads of big pharmaceutical companies, Thailand has issued the first compulsory license for a generic version of Merck & Co Inc.’s HIV-AIDS drug Efavirenz in an effort to lower costs.

Efavirenz is used as part of antiretroviral therapy for the treatment of HIV-AIDs, usually in conjunction with other HIV-AIDS drugs. The Thai government already uses other off-patent drugs to treat AIDS patients, but as patients live longer and require more advanced therapies, drug costs have skyrocketed.

Thailand’s state-owned pharmaceutical manufacturer, the Government Pharmaceutical...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.